Chen Jui-Yi, Chen Ying-Ying, Pan Heng-Chih, Hsieh Chih-Chieh, Hsu Tsuen-Wei, Huang Yun-Ting, Huang Tao-Min, Shiao Chih-Chung, Huang Chun-Te, Kashani Kianoush, Wu Vin-Cent
Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Clin Kidney J. 2022 Jan 14;15(5):974-984. doi: 10.1093/ckj/sfac011. eCollection 2022 May.
Critically ill patients with severe acute kidney injury (AKI) requiring kidney replacement therapy (KRT) have a grim prognosis. Recently, multiple studies focused on the impact of KRT initiation time [i.e., accelerated versus watchful waiting KRT initiation (WWS-KRT)] on patient outcomes. We aim to review the results of all related clinical trials.
In this systematic review, we searched all relevant randomized clinical trials from January 2000 to April 2021. We assessed the impacts of accelerated versus WWS-KRT on KRT dependence, KRT-free days, mortality and adverse events, including hypotension, infection, arrhythmia and bleeding. We rated the certainty of evidence according to Cochrane methods and the GRADE approach.
A total of 4932 critically ill patients with AKI from 10 randomized clinical trials were included in this analysis. The overall 28-day mortality rate was 38.5%. The 28-day KRT-dependence rate was 13.0%. The overall incident of KRT in the accelerated group was 97.4% and 62.8% in the WWS-KRT group. KRT in the accelerated group started 36.7 h earlier than the WWS-KRT group. The two groups had similar risks of 28-day [pooled log odds ratio (OR) 1.001, = 0.982] and 90-day (OR 0.999, = 0.991) mortality rates. The accelerated group had a significantly higher risk of 90-day KRT dependence (OR 1.589, = 0.007), hypotension (OR 1.687, < 0.001) and infection (OR 1.38, = 0.04) compared with the WWS-KRT group.
This meta-analysis revealed that accelerated KRT leads to a higher probability of 90-day KRT dependence and dialysis-related complications without any impact on mortality rate when compared with WWS-KRT. Therefore, we suggest the WWS-KRT strategy for critically ill patients.
需要肾脏替代治疗(KRT)的重症急性肾损伤(AKI)危重症患者预后严峻。最近,多项研究聚焦于KRT启动时间[即加速启动KRT与谨慎等待启动KRT(WWS-KRT)]对患者预后的影响。我们旨在综述所有相关临床试验的结果。
在这项系统评价中,我们检索了2000年1月至2021年4月期间所有相关的随机临床试验。我们评估了加速启动KRT与WWS-KRT对KRT依赖、无KRT天数、死亡率和不良事件(包括低血压、感染、心律失常和出血)的影响。我们根据Cochrane方法和GRADE方法对证据的确定性进行评级。
本分析纳入了来自10项随机临床试验的共4932例AKI危重症患者。总体28天死亡率为38.5%。28天KRT依赖率为13.0%。加速组KRT的总体发生率为97.4%,WWS-KRT组为62.8%。加速组KRT启动时间比WWS-KRT组早36.7小时。两组28天[合并对数比值比(OR)1.001,P = 0.982]和90天(OR 0.999,P = 0.991)死亡率的风险相似。与WWS-KRT组相比,加速组90天KRT依赖(OR 1.589,P = 0.007)、低血压(OR 1.687,P < 0.001)和感染(OR 1.38,P = 0.04)的风险显著更高。
这项荟萃分析表明,与WWS-KRT相比,加速KRT导致90天KRT依赖和透析相关并发症的可能性更高,且对死亡率无任何影响。因此,我们建议对危重症患者采用WWS-KRT策略。